Sanofi acquires US-based Blueprint Medicines for $9.1 billion, strengthening its portfolio in immunology and rare diseases.
Bill Gates to give away most of his $200 billion fortune through the Gates Foundation, with a focus on improving health, education, and development in Africa.
Sanofi acquires US-based Blueprint Medicines for $9.1 billion, strengthening its portfolio in immunology and rare diseases.
Bill Gates to give away most of his $200 billion fortune through the Gates Foundation, with a focus on improving health, education, and development in Africa.